GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novo Nordisk A/S (OTCPK:NONOF) » Definitions » Pretax Margin %

Novo Nordisk A/S (Novo Nordisk A/S) Pretax Margin % : 41.94% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Novo Nordisk A/S Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Novo Nordisk A/S's Pre-Tax Income for the three months ended in Dec. 2023 was $4,041 Mil. Novo Nordisk A/S's Revenue for the three months ended in Dec. 2023 was $9,636 Mil. Therefore, Novo Nordisk A/S's pretax margin for the quarter that ended in Dec. 2023 was 41.94%.

The historical rank and industry rank for Novo Nordisk A/S's Pretax Margin % or its related term are showing as below:

NONOF' s Pretax Margin % Range Over the Past 10 Years
Min: 38.39   Med: 41.91   Max: 45.07
Current: 45.07


NONOF's Pretax Margin % is ranked better than
95.81% of 1027 companies
in the Biotechnology industry
Industry Median: -176.72 vs NONOF: 45.07

Novo Nordisk A/S Pretax Margin % Historical Data

The historical data trend for Novo Nordisk A/S's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk A/S Pretax Margin % Chart

Novo Nordisk A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.79 41.85 41.96 39.03 45.07

Novo Nordisk A/S Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.93 46.35 44.67 47.78 41.94

Competitive Comparison of Novo Nordisk A/S's Pretax Margin %

For the Biotechnology subindustry, Novo Nordisk A/S's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novo Nordisk A/S's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novo Nordisk A/S's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Novo Nordisk A/S's Pretax Margin % falls into.



Novo Nordisk A/S Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Novo Nordisk A/S's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=15314.859/33982.121
=45.07 %

Novo Nordisk A/S's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=4041.084/9636.42
=41.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novo Nordisk A/S  (OTCPK:NONOF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Novo Nordisk A/S Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Novo Nordisk A/S's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Novo Nordisk A/S (Novo Nordisk A/S) Business Description

Address
Novo Alle 1, Bagsvaerd, DNK, DK-2880
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.